Medifast Inc.

AI Score

XX

Unlock

13.81
-0.20 (-1.43%)
At close: Mar 28, 2025, 3:59 PM
13.61
-1.48%
Pre-market: Mar 31, 2025, 06:10 AM EDT

Company Description

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.

The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.

It markets its products through point-of-sale transactions over ecommerce platform.

The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Medifast Inc.
Medifast Inc. logo
Country United States
IPO Date Dec 30, 1993
Industry Personal Products & Services
Sector Consumer Cyclical
Employees 504
CEO Daniel R. Chard

Contact Details

Address:
100 International Drive
Baltimore, Maryland
United States
Website https://medifastinc.com

Stock Details

Ticker Symbol MED
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000910329
CUSIP Number 58470H101
ISIN Number US58470H1014
Employer ID 13-3714405
SIC Code 2090

Key Executives

Name Position
Daniel R. Chard Executive Chairman & Chief Executive Officer
James P. Maloney CPA Chief Financial Officer
Anthony E. Tyree Chief Business Operations Officer
Claudia C. Greninger Chief Human Resources Officer
Jason L. Groves Esq. Executive Vice President, General Counsel & Corporate Secretary
Jonathan Barrett MacKenzie Vice President of Finance & Chief Accounting Officer
Nicholas M. Johnson Chief Field Operations Officer
Steven Zenker Vice President of Investor Relations

Latest SEC Filings

Date Type Title
Mar 27, 2025 4 Filing
Mar 27, 2025 4 Filing
Mar 27, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Feb 18, 2025 10-K Annual Report
Feb 18, 2025 8-K Current Report
Feb 11, 2025 5 Filing
Nov 13, 2024 SCHEDULE 13G/A [Amend] Filing